High-density array analysis of DNA methylation in Tamoxifen-resistant breast cancer cell lines |
| |
Authors: | Kristin E Williams Douglas L Anderton Maxwell P Lee Brian T Pentecost Kathleen F Arcaro |
| |
Affiliation: | 1.Molecular & Cellular Biology Graduate Program; Department of Veterinary & Animal Sciences; University of Massachusetts; Amherst, MA USA;2.Department of Sociology; University of South Carolina; Columbia, SC USA;3.Center for Cancer Research; National Institutes of Health; Bethesda, MD USA;4.Wadsworth Center; Albany, NY USA |
| |
Abstract: | Roughly two-thirds of all breast cancers are ERα-positive and can be treated with the antiestrogen, Tamoxifen, however resistance occurs in 33% of women who take the drug for more than 5 y. Aberrant DNA methylation, an epigenetic mechanism that alters gene expression in cancer, is thought to play a role in this resistance. To develop an understanding of Tamoxifen-resistance and identify novel pathways and targets of aberrant methylation, DNA from MCF-7 breast cancer cells and Tamoxifen-resistant derivatives, TMX2–11 and TMX2–28, were analyzed using the Illumina HumanMethylation450 BeadChip. Normalizing against MCF-7 values, ERα-positive TMX2–11 had 4000 hypermethylated sites and ERα-negative TMX2–28 had over 33 000. Analysis of CpG sites altered in both TMX2–11 and TMX2–28 revealed that the Tamoxifen-resistant cell lines share 3000 hypermethylated and 200 hypomethylated CpGs. ZNF350 and MAGED1, two genes hypermethylated in both cell lines, were examined in greater detail. Treatment with 5-aza-2′deoxycitidine caused a significant reduction in promoter methylation of both ZNF350 and MAGED1 and a corresponding increase in expression in TMX2–28. A similar relationship between methylation and expression was not detected in TMX2–11. Our findings are indicative of the variable responses to methylation-targeted breast cancer therapy and highlight the need for biomarkers that accurately predict treatment outcome. |
| |
Keywords: | Tamoxifen Resistance Breast Cancer Estrogen Receptor HumanMethylation450 BeadChip methylation ZNF350 MAGED1 |
|
|